+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Pharmaceuticals Market - Global Forecast 2026-2032- Product Image
Veterinary Pharmaceuticals Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Pharmaceuticals Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5612994
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Pharmaceuticals Market is projected to reach USD 48.57 Billion in 2026. It is expected to continue growing at a CAGR of 8.70%, reaching USD 80.31 Billion by 2032.

Veterinary pharmaceuticals are moving from episodic treatment toward preventive, data-enabled animal health management across companion animals and food-producing species. Demand is supported by rising pet ownership, protein consumption, zoonotic disease vigilance, and tighter expectations for animal welfare and food safety.

Verified industry signals reinforce the market's importance. The American Pet Products Association reported U.S. pet industry expenditures of USD 147.0 billion in 2023, while the World Organisation for Animal Health has noted that animal diseases cause at least 20% of global livestock production losses. These facts make vaccines, parasiticides, anti-infectives, analgesics, dermatology therapies, reproductive products, and biologics essential to resilient veterinary care.

Transformative Shifts in Veterinary Pharmaceuticals

The veterinary pharmaceutical landscape is being reshaped by antimicrobial stewardship, biologic innovation, and faster digital routes to veterinarians and animal owners. Regulation is moving toward more responsible use of medically important antimicrobials, with the European Union's Regulation 2019/6 restricting routine antibiotic use and the U.S. FDA maintaining veterinary oversight for medically important antimicrobial drugs.

At the same time, demand is shifting toward preventive portfolios, including vaccines, ectoparasiticides, endectocides, monoclonal antibodies, and long-acting formulations. Supply chains are also changing as companies invest in cold-chain capacity, regional manufacturing, serialization, and pharmacovigilance systems to protect product quality and regulatory trust.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator across veterinary pharmaceutical research, manufacturing, and post-market surveillance. AI-enabled modeling can improve target identification, screen compounds, optimize formulations, and detect safety signals from adverse event reports, electronic medical records, diagnostic images, and real-world treatment data.

The cumulative impact is strongest when AI is governed by validated data pipelines, explainable models, and regulatory-grade documentation. For industry leaders, AI is not a replacement for veterinary clinical evidence; it is a force multiplier that can reduce cycle time, improve pharmacovigilance sensitivity, support precision dosing, and strengthen customer engagement when aligned with FDA, EMA, WOAH, and VICH quality expectations.

Regional Dynamics Shaping Demand

Asia-Pacific is a high-volume arena because of its large livestock base, expanding aquaculture sector, and rising companion animal care in China, India, Japan, South Korea, and Australia. The FAO identifies Asia as a major center of global livestock and aquaculture production, making vaccines, antiparasitics, anti-infectives, and herd-health products central to disease control and food security. North America remains a premium region, supported by advanced veterinary clinics, high pet healthcare spending, strong FDA and Health Canada oversight, and continued investment in biologics, dermatology, pain management, and parasiticide innovation.

Latin America is anchored by Brazil and Mexico, where poultry, cattle, swine, and companion animal demand support broad veterinary pharmaceutical use. Europe is defined by EMA governance, Regulation 2019/6, antimicrobial stewardship, and high vaccine adoption, while the Middle East is investing in food security, equine health, camel health, and companion animal services. Africa presents long-term need for vaccines, antiparasitics, and cold-chain access, as WOAH and FAO continue to emphasize livestock health as central to rural livelihoods, zoonotic disease control, and sustainable food systems.

Strategic Group Insights

ASEAN demand is supported by poultry, swine, aquaculture, and companion animal growth, with governments emphasizing disease control, biosecurity, and vaccination after repeated regional outbreaks. The GCC is comparatively smaller but strategically important because of premium companion animal care, equine medicine, camel health, and food-security investments that depend on regulated veterinary inputs and reliable cold-chain distribution.

The European Union is a global reference point for pharmacovigilance, antimicrobial restrictions, residue control, and quality standards under EMA-led processes. BRICS countries combine scale and production intensity, especially in China, India, and Brazil, where livestock, aquaculture, and companion animal care create sustained need for vaccines, parasiticides, reproductive products, and anti-infectives. G7 markets lead in innovation, biologics, compliance, and pet therapeutics, while NATO countries overlap heavily with mature regulated markets, making supply resilience, biosecurity, and emergency preparedness important considerations for animal health security.

Country-Level Demand Signals

The United States is driven by high pet spending, advanced veterinary hospitals, and FDA Center for Veterinary Medicine oversight, while Canada emphasizes regulated access, herd health, companion animal care, and food safety. Mexico benefits from poultry, cattle, swine, and cross-border trade dynamics, and Brazil remains a major animal protein producer with strong demand for vaccines, parasiticides, reproductive medicines, and productivity-supporting therapies.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature veterinary pharmaceutical markets shaped by pet humanization, livestock biosecurity, vaccine uptake, and strict medicine controls, while Russia retains demand across food animals and companion animals despite supply-chain complexity. China and India offer scale in livestock, aquaculture, and companion animals, Japan and South Korea emphasize premium veterinary care, companion animal therapeutics, and innovation, Australia prioritizes biosecurity, ruminant health, and parasiticide use, and Pakistan shows continued need for affordable livestock pharmaceuticals, vaccine access, and stronger veterinary distribution.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize preventive medicine, antimicrobial stewardship, and differentiated companion animal portfolios. Investment should focus on vaccines, parasiticides, dermatology, pain management, reproductive health, biologics, and long-acting therapies that align with veterinarian workflow and measurable clinical outcomes.

Companies should strengthen regulatory intelligence, local market access, cold-chain execution, product serialization, and post-market safety systems. AI should be deployed for drug discovery, demand planning, pharmacovigilance, quality monitoring, and field-force effectiveness, but only with auditable datasets, cybersecurity safeguards, explainable models, and human veterinary oversight.

Research Methodology

The research applies a structured methodology combining secondary research, primary validation, and analytical triangulation. Sources include regulatory publications from FDA CVM, EMA, USDA, WOAH, FAO, national veterinary authorities, trade databases, peer-reviewed literature, animal health policy documents, and recognized industry associations.

Insights are validated by comparing demand indicators, disease burden, policy changes, product approvals, animal population trends, pharmacovigilance signals, and channel dynamics. The approach emphasizes verified evidence, transparent assumptions, and cross-regional consistency to support executive decision-making in veterinary pharmaceuticals without relying on market sizing, market share, or forecasting.

Strategic Conclusion

The veterinary pharmaceuticals market is becoming more preventive, regulated, digital, and evidence-led. Strategic direction will be shaped by the need to reduce disease-related livestock losses, improve companion animal quality of life, and support safe, sustainable food systems.

Organizations that combine scientific innovation with antimicrobial stewardship, regional execution, AI-enabled intelligence, and trusted veterinary relationships will be best positioned. The most durable advantage will come from portfolios that deliver measurable animal health outcomes while meeting rising expectations for safety, access, quality, and regulatory compliance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Pharmaceuticals Market, by Product Type
7.1. Introduction
7.2. Drugs
7.2.1. Analgesics
7.2.2. Anti-Infectives
7.2.2.1. Antibiotics
7.2.2.2. Antifungals
7.2.2.3. Antivirals
7.2.3. Anti-Inflammatories
7.2.3.1. NSAIDs
7.2.3.2. Corticosteroids
7.2.4. Parasiticides
7.2.5. Anaesthetics
7.2.6. Anesthetic
7.3. Medicated Feed Additives
7.4. Vaccines
7.4.1. Inactivated Vaccines
7.4.2. Live Attenuated Vaccines
7.4.3. Recombinant Vaccines
8. Veterinary Pharmaceuticals Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.2.1. Intramuscular
8.2.2. Subcutaneous
8.3. Oral
8.3.1. Chews
8.3.2. Liquid Suspension & Syrup
8.3.3. Tablets
8.4. Topical
8.4.1. Sprays
8.4.2. Powders
8.4.3. Ointments
9. Veterinary Pharmaceuticals Market, by Animal Type
9.1. Introduction
9.2. Companion Animals
9.2.1. Cats
9.2.2. Dogs
9.2.3. Horses
9.3. Livestock Animals
9.3.1. Cattle
9.3.2. Poultry
9.3.3. Sheep & Goats
9.3.4. Swine
10. Veterinary Pharmaceuticals Market, by Indications
10.1. Introduction
10.2. Chronic & Acute Pain Management
10.3. Immunological Conditions
10.4. Infectious Diseases
10.5. Metabolic Disorders
10.6. Neurological Disorders
10.7. Orthopedic Disorders
10.8. Parasitic Infections
10.9. Reproductive Health
11. Veterinary Pharmaceuticals Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
12. Veterinary Pharmaceuticals Market, by End User
12.1. Introduction
12.2. Animal Farms
12.3. Pet Owners
12.4. Veterinary Hospitals & Clinics
13. Veterinary Pharmaceuticals Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Veterinary Pharmaceuticals Market, by Group
14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC
15. Veterinary Pharmaceuticals Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. Canada
15.8. France
15.9. Brazil
15.10. Mexico
15.11. Italy
15.12. Australia
15.13. South Korea
15.14. Russia
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aurora Pharmaceutical, Inc.
17.2. Biogénesis Bagó S.A.
17.3. Biovac Ltd.
17.4. Boehringer Ingelheim International GmbH
17.5. Ceva Santé Animale
17.6. Chanelle Pharma
17.7. China Animal Husbandry Industry Co., Ltd.
17.8. Dechra Pharmaceuticals PLC
17.9. ECO Animal Health Group PLC
17.10. Elanco Animal Health Incorporated
17.11. Heska Corporation by Mars, Incorporated
17.12. Hester Biosciences Limited
17.13. Indian Immunologicals Ltd.
17.14. Intas Pharmaceuticals Ltd.
17.15. Laboratorio Drag Pharma Chile Invetec S.A.
17.16. Merck & Co., Inc.
17.17. Neogen Corporation
17.18. Norbrook Group
17.19. Phibro Animal Health Corporation
17.20. Teknofarma S.r.l.
17.21. Vetoquinol Group
17.22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
17.23. Virbac S.A.
17.24. Zendal Group
17.25. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL VETERINARY PHARMACEUTICALS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY PHARMACEUTICALS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ANAESTHETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ANAESTHETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ANAESTHETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ANESTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ANESTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ANESTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MEDICATED FEED ADDITIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MEDICATED FEED ADDITIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MEDICATED FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CHEWS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CHEWS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CHEWS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL LIQUID SUSPENSION & SYRUP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL LIQUID SUSPENSION & SYRUP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL LIQUID SUSPENSION & SYRUP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TABLETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL POWDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CHRONIC & ACUTE PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CHRONIC & ACUTE PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CHRONIC & ACUTE PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL IMMUNOLOGICAL CONDITIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL IMMUNOLOGICAL CONDITIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL IMMUNOLOGICAL CONDITIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL ANIMAL FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL ANIMAL FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL ANIMAL FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 179. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 180. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 181. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 182. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 183. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 184. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 185. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 186. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 188. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 189. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 190. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 193. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 195. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 196. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 203. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 209. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 211. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 212. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 213. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 214. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 225. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 227. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 228. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 229. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 230. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 231. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 232. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 233. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 234. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 235. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 236. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 237. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 238. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 239. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 247. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 248. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 249. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 250. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 257. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 258. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 259. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 260. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 261. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 262. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 263. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 264. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 265. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 266. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 267. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 268. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 269. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 270. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 271. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 273. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 274. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 275. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 276. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 277. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 278. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 279. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 280. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 281. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 282. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 283. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 284. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 285. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 286. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 287. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 288. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 306. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 307. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 308. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 309. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 310. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 311. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 312. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 313. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 314. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 315. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 316. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 317. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 318. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 319. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 320. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 322. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 323. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 324. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 325. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 326. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 327. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 328. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 329. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 330. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 331. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 332. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 333. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 334. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 335. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 338. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 340. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 341. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2017-2032 (USD MILLION)
TABLE 342. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 343. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 344. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 345. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 346. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 347. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 348. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 349. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 350. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2017-2032 (USD MILLION)
TABLE 351. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 352. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 353. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 354. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 355. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 356. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2017-2032 (USD MILLION)
TABLE 357. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2017-2032 (USD MILLION)
TABLE 358. UNITED STATES VETERINARY PHARMA

Companies Mentioned

  • Aurora Pharmaceutical, Inc.
  • Biogénesis Bagó S.A.
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation by Mars, Incorporated
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec S.A.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Group
  • Phibro Animal Health Corporation
  • Teknofarma S.r.l.
  • Vetoquinol Group
  • Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • Virbac S.A.
  • Zendal Group
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 48.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 80.31 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Veterinary Therapeutics Market - Global Forecast 2026-2032 - Product Image

Veterinary Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027)

  • Training
  • 1 Day
  • Global
Veterinary Drug Market - Global Forecast 2026-2032 - Product Image

Veterinary Drug Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.